Medical Cannabis in Greece
Greece is currently discussing a new bill about medical cannabis products. The proposal is entitled: Production, Export and Distribution of final medical cannabis products made from Cannabis Sativa L. with a Tetrahydrocannabinol (THC) content of more than 0,2%.
Greece legalized medical cannabis in 2017, and repealed a ban on cultivation and production in March 2018. However, growers and producers must set up a Greek company to buy or lease land, prepare the documentation for the installation license and then apply for an operations license and a medical license from the National Organization for Medicines to begin cultivation and / or production.
Exported products will be solely subject to the laws and regulations in the country importing them
The purpose of the proposal is to allow medical cannabis companies in Greece, to produce medical cannabis and export it to Europe. According to the proposal, the medical cannabis would not be subject to the same laws as that sold domestically, which must follow the existing legislation calling for approval by the Hellenic Organization of Pharmaceuticals. Exported products will be solely subject to the laws, regulations and GMP/GDP guidelines in the country importing them.
For more information please visit the portal of the Hellenic parliament.
Related GMP News
15.10.2024Real-World Data Requirements for Herbal Medicinal Products
01.08.2024USP Cannabis Monograph
01.08.2024FDA issues Warning Letters for Selling Products containing Delta-8 THC
28.05.2024New USP Proposal for CBD Monograph
28.05.2024Revised German Cannabis Monograph